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Abstract
Warfarin is a widely used oral anticoagulant
worldwide. However, due to the complex relationship
between individual factors, it is challenging to estimate
the optimal warfarin dose to give full play to its ideal
efficacy. Currently, there are plenty of studies using
machine learning or deep learning techniques to help
with the optimal warfarin dose selection. But few of
them can resolve missing values and high-dimensional
data naturally, that are two main concerns when
analyzing clinical real world data. In this work,
we propose to regard each patient’s record as a set
of observed individual factors, and represent them in
an embedding space, that enables our method can
learn from the incomplete date directly and avoid
the negative impact from the high-dimensional feature
set. Then, a novel neural network is proposed to
combine the set of embedded vectors non-linearly,
that are capable of capturing their correlations and
locating the informative ones for prediction. After
comparing with the baseline models on the open source
data from International Warfarin Pharmacogenetics
Consortium, the experimental results demonstrate that
our proposed method outperform others by a significant
margin. After further analyzing the model performance
in different dosing subgroups, we can conclude that
the proposed method has the high application value in
clinical, especially for the patients in high-dose and
medium-dose subgroups.
1. Introduction
Warfarin is a widely used anticoagulation for the
treatment of non-valvular atrial fibrillation and venous
thromboembolism [1]. However, due to its narrow
therapeutic window and the large individual factor
variability, especially for warfarin sensitive patients,
it is difficult to deliver the optimal warfarin dose
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Figure 1. (a) An example of common data
processing way. (b) An example of how we
transforming and processing the original data from
each individual patient.
[2], that the percentage of patients in the warfarin
therapeutic window is even less than 60%, despite
frequent use of INR for monitoring [3]. Therefore, the
appropriate determination of warfarin dose is critical to
its effectiveness and safety in clinical.
Till date, remarkable efforts have been invested
to develop warfarin dose prediction models on the
integration of clinical, demographic and genetic features
for individual patients [1, 4–6], in which multivariate
linear regression (MLR) is one of most common dosing
algorithms [1, 7, 8]. However, linear models lack of
effectiveness of learning non-linear relations and may
not fit well to a certain subset of patients [9]. To avoid
this, machine learning and deep learning approaches
have been proposed recently, such as support vector
machine (SVM) [10], decision tree based algorithms
[11] and neural networks [4], that they are capable of
capturing the complex relationships among individual
factors and enhance the model performance. Both





linear and machine learning models are constructed on
the set of 1-dimensional vectors in some feature space
(Shown in Figure 1a.), that always encounter two major
challenges, high-dimension and missing values [12],
because patients will not all examinations in hospital
and their clinical features are various to each other, such
as medications and indications. These two concerns are
what our method aims to resolve.
For dealing with missing values, a typical strategy is
to fill them by generating candidates from the existing
data distribution, such as the maximum value, average
value, and candidates computed by MICE or KNN [13–
15]. When the missing rate remains at the low level, data
imputation methods are with high accuracy. However,
they are not solid on the highly incomplete data sets,
such as more than 50% of the features with more than
80% missing rate [16], since the observed data is not
able to represent the overall distribution and imputation
techniques will bring much extra noise to interfere with
the final prediction. Instead of filling missing values,
predictive models can be constructed under certain
assumptions of missing mechanisms without imputation
required in prior, and their decision functions can be
relied on the witnessed data only [17–19]. While, all
these methods are based on the fixed feature space,
which will always be high-dimensional, especially in the
data sets from real-world settings, and their performance
will be negatively influenced. In our study, we not only
learn from the incomplete data directly, but also resolve
the high-dimension problem.
The common way for processing high-dimensional
data set is feature selection to enhance the predictive
performance, provide more cost-effective models, and
provide the understanding of underlying data pattern
[20]. There are three main strategies of feature
selection [21], filter methods, wrapper methods, and
embedded methods. The key concept in filter methods
is feature ranking or ordering by the feature relevance
measurement [22–24], and different from it, wrapper
methods use predictive performance as the objective
function to evaluate the usefulness of feature subset
[25, 26]. As for embedded methods, they are developed
to reduce the computation time when reclassifying
different subsets from wrapper methods, and incorporate
feature selection in training process [27, 28].
In this work, we address both high-dimensional
feature space problem and missing values at the same
time in an alternative way, that we view each patient’s
record as a set of observed features and map them to
an embedding space via feature embedding (Shown in
Figure 1b.). Through this way, our proposed method
can learn from incomplete and high-dimensional data
directly and naturally without any initial operation.
After incorporating with a novel neural network, which
is capable of exploring the correlations among the
embedded vectors from the observed features and
robust to the large amount of invalid information,




In this work, in order to capture the complex
relationships of the embedded vectors from observed
features, we use a state-of-art technique from the
NLP community, Transformer [29], that is originally
proposed for the neural machine translation (NMT)
tasks and use self-attention mechanism to resolve the
long distance dependency problem. Currently, it has
been widely applied in real-world applications such as
recommender system [30], automatic knowledge graph
construction [31] and speech recognition [32, 33].
The key idea of Transformer is the proposed
multi-head attention, that enables the model to capture
associations between the input words in different
embedding subspaces, named as heads. Moreover,
there exists a novel computational module, feed-forward
network (FFN), in Transformer to further enhance the
representation abilities of the vectors from multi-head
attention module [34].
In our study, we consider each patient’s record as a
set of observed features. Through feature embedding,
multi-head attention and FFN in Transformer, an
optimal feature representation space for warfarin dose
prediction is able to obtained. Notably, when we use
techniques from Transformer, the position encoding
vectors of words are excluded, since there is no
sequential information existing.
2.2. Multi-Instance Pooling
As the key step in multi-instance neural network
(MINN) [35], multi-instance pooling is to obtain
the informative bag or instance representation, that
bridges the bag space and instance space [36].
Typically, there are two main strategies of adopting the
multi-instance pooling on MINN, that are trainable ones
and non-trainable ones [37].
Non-trainable multi-instance pooling methods are
the most common in MINN, such as max pooling
[35], average pooling [38] and sum pooling [39].
They use straightforward data operation to obtain their
appropriate representations and uncover the hidden
patterns among instances and bags. In addition,
there are some novel trainable multi-instance pooling
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Figure 2. (a) The overall architecture of our proposed method, that consists of two levels, a feature embedding
module to map the observed information to en embedding space and a novel neural network with multi-head
attention, feed-forward network and multi-instance pooling to fully explore the hidden patterns among features
for the final prediction. The whole process is trained jointly in end-to-end. (b) Multi-head attention is adopted in
our method to uncover the correlations of embedded vectors, i.e., observed features. Notably, through multi-head
attention the relations between Grep and the other embedded vectors can also be captured, which is used to
represent the overall patient information for the further processing.
methods proposed, such as gated attention based MIL
pooling [40], attention based MIL pooling [40] and
dynamic pooling [36]. These pooling methods can
help MINNs with the key instance selection through
assigning different weights for them. Multi-instance
pooling techniques, no matter trainable or non-trainable
ones, enable the model to avoid the negative influence
introduced by the invalid information to enhance the
performance.
Normally, MINN is a typical framework for
classification tasks and multi-instance pooling plays
a crucial role, while in our work, we adopt it for
regression, that we regard the final representation vector
as a bag of instances and use max pooling to compute
the bag representation for the final warfarin dosing
prediction.
3. Methodology
In order to estimate the appropriate warfarin dose
on incomplete and high-dimensional data, we propose
a novel framework, that each patient (X , y) is
initially transformed to a set of observed feature-value
pairs X = {(f1, v1), (f2, v2), . . . , (fn, vn)} with the
corresponding optimal warfarin dose y, and feature
fj (j = 1, 2, . . . , n) is either binary f bj , ordinal
or continuous f cj . Notably, all nominal features are
one-hot encoded to binary ones during transformation
process. Our objective is to train a regressor to
predict y from the feature set X . Specifically,
our modeling strategy consists of two levels, that
the underlying part is to represent each observed
feature-pair (fj , vj) by a d dimensional embedded
vector gf = g(fj , vj) ∈ Rd. The second level is a novel
neural network to capture the complex correlations in
G and locate the valuable information in G for the
warfarin optimal dose y ∈ R estimation, where G =
{grep, g(f1, v1), g(f2, v2), . . . , g(fn, vn)} and gRep is
an embedded vector of a representation feature, which
is added in the feature set representing all observed
information, i.e., the overall body condition. These
two parts are parameterized and trained jointly in an
end-to-end manner. The overall architecture is shown
in Figure 2a.
3.1. Feature Embedding
For each patient, the observed features is first
transformed to the feature-value pairs and in order to
make them applicable to feature embedding, we design
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two different strategies in terms of their different types:
• Binary and Nominal Features: As mentioned
above, nominal features are initially one-hot
encoded to binary ones and in feature embedding,
we only include the binary features f b with the
positive responses, i.e., only the exposure factors
are included into predictive modeling.
• Continuous and Ordinal Features: As for
continuous and ordinal features, we standardize
and scale their corresponding vaues to 0 to 1
by (f c(i)−min (f c)) / (max (f c)−min (f c))
where f c(i) is the ith sample in the continuous
or ordinal feature f c.
After preprocessing, each patient X can be denoted
as X = {f brep, f b1 , . . . , f bn1 , (f
c
1 , v1), . . . , (f
c
n2 , vn2)},
where f brep is a self-defined binary feature with positive
response. Through embedding and multi-head attention,
f brep can represent the overall body condition and be
used for the final prediction. Subsequently, f b and f c
are embedded via two different ways, that for f b, we
parameterize it through:
g(f b) = Lfb where Lfb ∈ Rd (1)
Lfb is a d-dimensional parameter vector, which
optimized by the back propagation. As for f c, we map
it to the embedding space by:
g(f c, v) =W c(vLfc/d) (2)
where Lfc ∈ Rd is also a parameter vector of d
dimensions and v is the corresponding value of f c.
W c ∈ Rd×d is used as capacity control to adjust the
contributions of the value v on the parameter vectorLfc .
At last, we combine all obtained embedded vectors
from f b and f c respectively, and adopt the layer
normalization [41] as our feature embedding output:
Gf = LayerNorm
([
g(f b), g(f c, v)
])
(3)
Through feature embedding, we can map all
observed feature to an informative embedding space,
that the negative effects of missing values and high
dimensional features are also naturally avoided,
and leaves great flexibility to analyze the potential
associations between features by the following
technique, multi-head attention.
3.2. Multi-Head Attention
The multi-head attention module we used is identical
to the one originally defined by [29] except that
we exclude the position encoding part, since there
is no sequential information existing. There are
two computation part in multi-head attention, scaled
dot-product attention and multi-head transformation. In
scaled dot-product attention, three input vectors with
dk dimensions are received, a query Q, key K and the
corresponding value V and the output is obtained by:






In this work, we mainly focus on the mining of
potential associations between observed features, so
Q,K, V are all the embedded vector Gf from the
previous feature embedding:









In addition, to fully uncover the underlying relations
of Gf , multi-head attention allows to access several















r are three linear projections for Gf . Then
they are concatenate as the final output of multi-head
attention:
MultiHead(Gf , Gf , Gf ) = [H1; . . . ;HR]W
4 (7)
where W 4 is the output projection. Through this way,
the associations between the self-defined representation
vector grep and other observed features can be explored,
that allows grep can represent the patient’s current
medical condition and be used for the further warfarin
dose estimation.
3.3. Feed-Forward Network
After multi-head attention, we adopt feed-forward
network, consisting of two 1-dimensional convolution
layers with kernel size equals to 1 and ReLu activation
in between, to further enhance the representation
capability of Gf :
FFN(x) = Conv1D(max (0,Conv1D(x))) (8)
Through feed-forward network we can obtain our
final vector set T = {trep, t1, t2, . . . , tn} and we only
include the self-defined representation vector trep with




As the key step in MINN, multi-instance pooling
enables models to avoid the interference from noise and
invalid information [39]. Out of this consideration, we
adopt multi-instance pooling instead of common used
fully connected layer as our final output layer to get
the predicted warfarin dose. Moreover, our objective
is a regression task and the trainable multi-instance
pooling methods typically generates weights between 0
and 1, that are more suitable for classification instead
of regression tasks, so we adopt a non-trainable method,
max pooling.
Output = max (tk = {w1, w2, . . . , wd}) (9)
wi ∈ R is a parameter in the representation vector tk.
After we obtain the final output, we compute the
loss with the true value y and train our model by back
propagation in end-to-end way.
4. Experiments
4.1. Data Description
The data we used for modeling is the open source
IWPC cohort which has been described previously
by [1] and can be downloaded from the PharmGKB
website (http://www.pharmgkb.org/downloads/). The
data set contains 6256 warfarin users from 4 continents
with demographic factors, clinical features, such as
age, weight, height, indications and united medication,
as well as CYP2C9 and VKORC1 genotypes. We
exclude the subjects without reaching stable doses of
warfarin and the therapeutic doses of warfarin are
missing. A total of 5410 subjects are included in our
study. Moreover, we include all 8 indications, 1458
comorbidities and 1917 medications, so the dimensions
of the dataset are in high level. Besides, the data set
is with a large number of missing values with 41.8%
missing rate on average. The detailed statistics of our
included data are shown in Table 1.
4.2. Experimental Settings
We map feature-pairs to an embedding space with
512 dimensions and processed by the multi-head
attention with 8 heads, i.e., 8 embedding sub-spaces
to mine underlying relationships. In feed-forward
network, we set two convolution layers with 1024
and 512 dimensions, respectively. Moreover, in each
computational module, the dropout layer [42] is added
with the 0.3 dropout rate to prevent model overfitting.
Our method is trained by Adam optimizer [43] with 300
Table 1. Statistics of the Data Set
Included Patients 5410
Binary or Nominal Features 3395
Continuous or Ordinal Features 4
Max. Observed Features 58
Min. Observed Features 5
Average Missing Rate 41.8%
Max. Missing Rate 83.8%
epochs and 5e−6, that ε is 1e−8 and the momentum
parameters β1, β2 are set to 0.9 and 0.98. Moreover,
for the sake of fairly comparison, we design ”early
stopping” mechanism on five-fold cross validation in
terms of R2, MAE (Mean Absolute Error) and MSE
(Mean Squared Error). The loss function we used is




log cosh(ytrue − ypred) (10)
where ytrue is the true value and ypred denotes the
predicted value on the ith sample.
4.3. Baselines
To comprehensively evaluate our proposed method,
we first compare it with three advanced machine
learning methods XGBoost [44], LightGBM [45] and
CatBoost [46], and to obtain the best performance of
machine learning performance, we use AuoML method
[47] to select the best parameter set automatically. They
are all decision tree based methods, not only can learn
from incomplete data directly, but also robust to sparse
data, that are exactly two challenges we meet.
In addition, to demonstrate the effectiveness of what
we used multi-instance pooling method, we conduct
the performance comparisons by using fully connected
layer, max pooling, mean pooling [39], attention based
pooling, and gated attention based pooling methods [40]
in our proposed framework.
5. Results and Analysis
5.1. Performance Comparisons
We first compare our proposed method with three
advanced machine learning techniques, and then we
evaluate the performance of our method with different
pooling methods to generate the final output. The
detailed comparison results are shown in Table2, that we
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Table 2. Comparison with Baseline Methods for Warfarin Dose Estimation
Strategy Models R2 MAE MSE
Machine Learning Techniques
XGBoost-AutoML 0.420 8.979 167.972
LightGBM-AutoML 0.327 9.495 190.347
CatBoost-AutoML 0.427 8.773 163.884
With Different Pooling Methods
Fully Connected Layer 0.405 8.742 168.549
Mean Pooling 0.418 8.626 165.069
Att. Pooling 0.426 8.639 163.122
Gated Att. Pooling 0.424 8.580 163.558
This Work Max Pooling 0.437 8.471 160.016
use R2, MAE and MSE as our evaluation metrics. The
larger the R2, the better, MAE and MSE are opposite.
As demonstrated, our proposed method achieves
consistent better results compared with all baseline
methods, that the R2, MAE and MSE are 0.437,
8.471 and 160.016, respectively. Surprisingly, CatBoost
performs much better than XGBoost and LightGBM,
illustrating its superiority of processing categorical and
sparse matrix, which is one of the characteristics of
the data we use. Moreover, the comparison results of
fully connected layer and other multi-instance pooling
methods, shows the deficiencies of fully connected
layer in effective information location, that its R2 is
only 0.405. As for attention based (Att. Pooling)
and gated attention based multi-instance pooling (Gated
Att. Pooling), the key idea is to assign different
weights for instances to adjust their contributions, but
the weights are all from 0 to 1, which may limit the
model performance on regression tasks. The R2 for Att.
Pooling and Gated Att. Pooling are 0.426 and 0.424,
respectively, lower than our used max pooling.
5.2. Impact of Multi-Head Attention
To measure the impact that the multi-head attention
introduces, we conduct experiments for our method with
0, 2, 4, 6, 8, 10, and 12 heads, respectively, where 0
heads denotes that multi-head attention is not employed
and integrated in our proposed neural network. The
evaluation results are depicted in Figure 3.
The number of 8 heads gives the best model
performance, i.e., relations capture in 8 subspaces can
be fully uncovered, which brings clinical instructions
that the features we used can be considered in 8 aspects
and in each one, features are with their own hidden
associations. More importantly, our experiments prove
the effectiveness of multi-head attention in our method
Figure 3. The Performance Comparisons of Different
Number of Heads
since if we remove it, the R2 drop to 0.417. It
also illustrates the complex relations between clinical
features existing in warfarin users, and correlations
exploration is necessary.
5.3. Dose Subgroup Analysis
In this subsection, we mainly focus on evaluating
the clinical applicability of our method on different
dose subgroups. Follow the same criteria described
in [1], warfarin doses are divided into low dose group
≤ 21mg/wk, medium dose group> 21 to< 49mg/wk,
and high dose group ≥ 49mg/wk. In different
subgroups, we measure the model clinical applicability
using ideal predictive percentage (IPP) [1], indicating
the percentages of the predicted dose within the 20%
interval of the actual dose.
As shown in Figure 4, our method is with high
clinical applicability, especially in the medium and high
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Figure 4. The IPPs Comparison in Different Dose
Subgroups
Table 3. Comparisons of Our Method on Different
Feature Sets
Feature Set R2 MAE MSE
CF 0.412 8.612 163.559
Cl 0.383 8.972 174.648
GF 0.395 8.910 169.513
This Work (Mixed) 0.437 8.471 160.016
dose group, the IPPs are 0.646 and 0.492, respectively.
Moreover, high and low dose groups are with lower
IPP than the medium group, revealing that patients in
medium dose group are with less clinical variability and
more stable disease condition, making them easier to
obtain the optimal warfarin dose from the predictive
models.
5.4. Different Feature Sets
At last, we evaluate our method on four different
combinations of features, only continuous or ordinal
features (CF), only clinical factors with the exclusion of
CF and genetic variables (Cl), only the genetic features
(GF), and all features (Mixed). Table 3 records the
comparison results detaily.
As shown, compared to the other clinical features,
the continuous or ordinal features, such as age, weight,
height, target INR, and genetic variables provides the
main guidance and instruction for optimal warfarin dose
prediction. However, clinical features also contain
fruitful information for dose estimation, so mixing them
together to obtain the comprehensive clinical guidance
is the best option for modeling.
6. Conclusion
This paper presents a novel and applicable way
for warfarin dose estimation on incomplete and
high-dimensional data, that data imputation and feature
selection is not required priorly through transforming
observed information into feature-value pairs and
modeling on them. Specifically, it consists of two
levels, and the first level is a feature embedding module
to map all observed information to an embedding
space to avoid missing values and redundant features
naturally. Based on the embedded vectors, the second
modeling level is developed by a novel neural network,
that not only can capture the underlying and complex
relationships among features, but also can isolate the
invalid information and noise to make the better warfarin
dose determination.
The two main contributions of our method are
feature embedding and multi-instance pooling. Through
feature embedding, we can obtain an informative
embedding space, that leaves great flexibility of further
operation. For example, we can use many NLP
techniques to discover our interested information, and
the only thing to notice is the removal of the sequential
information. The other one is the multi-instance
pooling, that it is capable of protect our model
from large amount of invalid information. More
importantly, multi-instance pooling is normally used for
the classification tasks, but in our method, we have
demonstrated its feasibility of applying to regression
problems, that the application of this technique has been
expanded.
In the future work, we try to expand our current
method to deal with temporal data, such as frequent
physical test results and lab test results, and discover
more hidden patterns among them.
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